AGP Picks View all

Thumbay International Pathway marks 10 years with 90 doctors in Poland track

5 hours ago
Thumbay International Pathway marks 10 years with 90 doctors in Poland track

By AI, Created 5:21 PM UTC, June 02, 2026, /AGP/ – Gulf Medical University and the Medical University of Lublin celebrated the 10th year of their Thumbay International Pathway with a June 2 convocation in Poland honoring 90 doctors who trained in Ajman and graduated in Lublin. The milestone underscores a growing cross-border medical route that now spans 62 nationalities and has enrolled GMU’s 10th cohort.

Why it matters: - The Thumbay International Pathway has become a direct route for students to earn a European medical degree after pre-clinical study in Ajman. - The program has now produced 90 doctors, showing the partnership has moved from pilot model to established pipeline. - Students from more than 45 nationalities are currently enrolled, which broadens the pathway’s reach beyond the UAE.

What happened: - The Medical University of Lublin held a convocation on June 2 in Lublin, Poland, to honor students in the Thumbay International Pathway – Poland. - Gulf Medical University said the program has entered its tenth year and has enrolled its 10th cohort. - The ceremony recognized students who completed pre-clinical study in Ajman and continued to clinical training in Lublin before earning an MD degree.

The details: - The pathway launched in 2017 as an associate degree in Preclinical Sciences. - In 2022, the Commission for Academic Accreditation renewed the program and changed it to a Higher Diploma in Preclinical Sciences, a Level 6 qualification. - The model includes three years of pre-clinical study at GMU and three years of clinical training at the Medical University of Lublin. - The final MD degree is awarded by the partner university in Poland and is recognized across the European Union. - An articulation agreement supports transfer between the two universities. - Since 2017, students from 62 nationalities have enrolled in the pathway. - The first cohort graduated from Lublin in 2023. - Enrollment has increased each year since the first graduation. - The June 2 convocation was held in the presence of Dr. Thumbay Moideen, Founder President of Thumbay Group. - A link for more information is available here: More details

Between the lines: - The program’s growth suggests steady demand for a structured international medical route with a clear transfer path. - The expanding mix of nationalities indicates the pathway has evolved into an international recruitment channel, not just a regional one. - Public recognition from both university leaders signals the partnership is being positioned as a long-term institutional success, not a one-off graduation event.

What’s next: - GMU’s newest cohort is now in the pipeline toward the same Ajman-to-Poland degree track. - The partnership is likely to continue sending students from pre-clinical study in the UAE into clinical training in Poland as long as enrollment holds steady. - The universities are expected to build on the pathway’s tenth-year milestone as more students complete the full program.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

World Education News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Sign up for:

World Education News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.